Observational studyJournal of global health2026
Association of maternal longitudinal haemoglobin concentrations with adverse pregnancy outcomes: A prospective cohort study.
Observational study in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04486456 (Epidemiological Study on Anemia and Iron Deficiency in Pregnancy in Medical Institutions in Some Areas of China), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Epidemiological Study on Anemia and Iron Deficiency in Pregnancy in Medical Institutions in Some Areas of China
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maternal haemoglobin (Hb) is a potential biomarker of maternal and neonatal health. Little is known about trimester-specific associations between maternal Hb concentrations and adverse pregnancy outcomes. Here, we assessed the magnitude and shape of these associations and further estimated developmental trajectories of maternal Hb concentrations during pregnancy. Methods: In this prospective, observational cohort study, we enrolled pregnant women at 11-13 weeks of gestation from 13 hospitals of northern China between October 2020 and June 2024. We classified maternal Hb concentrations in the first, second, and third trimester (i.e. 11-13, 24-27, and 36-40 weeks' gestation, respectively) into three groups: <110 g/L, 110-129 g/L, and ≥130 g/L, respectively. We used logistic regression models, restricted cubic spline analysis, and group-based trajectory models to examine the association between maternal Hb concentrations and pregnancy outcomes. Results: Among 10 201 participants, maternal Hb concentrations of ≥130 g/L in the first, second, and third trimester were associated with increased odds of gestational diabetes mellitus and hypertension in pregnancy. Maternal Hb concentrations of <110 g/L in the second trimester were associated with higher odds of postpartum haemorrhage (odds ratio (OR) = 1.38; 95% confidence interval (CI) = 1.04-1.83). Maternal Hb concentrations of ≥130 g/L in the third trimester were associated with higher odds of small-for-gestational-age (OR = 1.48; 95% CI = 1.23-1.79) and low birth weight (OR = 1.55; 95% CI = 1.11-2.16). We further identified a U-shaped relationship between maternal Hb concentrations in the third trimester and small-for-gestational age (P-value for nonlinearity = 0.002). Lastly, high Hb trajectories during pregnancy were associated with higher odds of caesarean delivery (OR = 1.21; 95% CI = 1.10, 1.34), small-for-gestational age (OR = 1.41; 95% CI = 1.16, 1.72) and low birth weight (OR = 1.46; 95% CI = 1.03, 2.05). Conclusions: Both higher and lower maternal Hb concentrations were associated with higher odds of adverse pregnancy outcomes. Our findings emphasise the importance of longitudinal monitoring of maternal Hb concentrations throughout pregnancy. Registration: ClinicalTrials.gov: NCT04486456.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.